Valeant Pharmaceuticals (VRX +3.2%) trades higher as the Street comments on an upbeat analyst...

|About: Valeant Pharmaceuticals Int... (VRX)|By:, SA News Editor

Valeant Pharmaceuticals (VRX +3.2%) trades higher as the Street comments on an upbeat analyst day, one that saw the drug developer raise its 2012 guidance to the high end of prior ranges. Jefferies (Buy) declares Valeant to be an "excellent," albeit "controversial" investment, and is impressed with its guidance in light of the company's 20%+ Euro exposure.